For the first time since 2005, the DRIs for sodium and potassium have been reviewed and updated. Presenters will demonstrate how the use of systematic reviews and other new tools and resources allowed the review panel to derive the DRIs, including the application of chronic disease endpoints to DRIs. This presentation will also show how the updated DRI values are now more compatible than previously with the goal of optimizing health across the lifespan and reducing risk of chronic disease associated with sodium and potassium intake.
Participants who attended the webinar were able to:
Describe the key steps in the process used to develop DRIs for sodium and potassium.
Identify and describe at least one new tool used to assess the evidence for deriving DRI values for sodium and potassium.
Describe the utility and application of the Chronic Disease Risk Reduction Intake (CDRR) for optimizing health and reducing risk of chronic disease.